Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assay of factor VIII:C with a chromogenic substrate.

× No keyword cloud information.

12 in total

1. Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays.

Authors: V S Hornsey; Y G Waterston; C V Prowse
Journal: J Clin Pathol Date: 1988-05 Impact factor: 3.411

Review 2. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.

Authors: S Björkman; E Berntorp
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 6.447

3. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.

Authors: Jerry S Powell; Neil C Josephson; Doris Quon; Margaret V Ragni; Gregory Cheng; Ella Li; Haiyan Jiang; Lian Li; Jennifer A Dumont; Jaya Goyal; Xin Zhang; Jurg Sommer; Justin McCue; Margaret Barbetti; Alvin Luk; Glenn F Pierce
Journal: Blood Date: 2012-01-05 Impact factor: 22.113

4. Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.

Authors: M Anvret; M Blombäck; M Lindstedt; E Söderlind; M Tapper-Persson; A C Thelander
Journal: Hum Genet Date: 1992-05 Impact factor: 4.132

5. Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies.

Authors: S Björkman; M Carlsson; E Berntorp; P Stenberg
Journal: Clin Pharmacokinet Date: 1992-05 Impact factor: 6.447

6. Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.

Authors: K M Brinkhous; H Sandberg; J B Garris; C Mattsson; M Palm; T Griggs; M S Read
Journal: Proc Natl Acad Sci U S A Date: 1985-12 Impact factor: 11.205

7. Development and characterization of lipidic cochleate containing recombinant factor VIII.

Authors: Razvan D Miclea; Prashant R Varma; Aaron Peng; Sathy V Balu-Iyer
Journal: Biochim Biophys Acta Date: 2007-08-19

8. Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years: a population analysis based on 50 patients with long-term prophylactic treatment for haemophilia A.

Authors: Sven Björkman; Anna Folkesson; Siv Jönsson
Journal: Eur J Clin Pharmacol Date: 2009-06-26 Impact factor: 2.953

9. Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.

Authors: V J Dwarki; P Belloni; T Nijjar; J Smith; L Couto; M Rabier; S Clift; A Berns; L K Cohen
Journal: Proc Natl Acad Sci U S A Date: 1995-02-14 Impact factor: 11.205

10. Biochemical and cellular markers differentiate recovered, in-line filtered plasma, and plasma obtained by apheresis methods.

Authors: Jürgen Siekmann; Alfred Weber; Christoph Bauer; Peter L Turecek
Journal: Vox Sang Date: 2021-06-10 Impact factor: 2.996